For: | Zhang X, Jin WW, Wang HG. Correlation between the neuroendocrine axis, microbial species, inflammatory response, and gastrointestinal symptoms in irritable bowel syndrome. World J Gastroenterol 2024; 30(35): 3985-3995 [PMID: 39351052 DOI: 10.3748/wjg.v30.i35.3985] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i35/3985.htm |
Number | Citing Articles |
1 |
Lemonica Koumbi, Maria-Anna Giannelou, Lorys Castelli. The gut–brain axis in irritable bowel syndrome: neuroendocrine and epigenetic pathways. Academia Biology 2025; 3(2) doi: 10.20935/AcadBiol7748
|
2 |
Raffaele Pellegrino, Antonietta Gerarda Gravina. Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage. World Journal of Gastroenterology 2025; 31(8): 101357 doi: 10.3748/wjg.v31.i8.101357
|
3 |
Martin D. Lehner, Philippe Ulsemer, Sandra Christochowitz. Menthacarin, a proprietary combination of peppermint and caraway oil, alters cultured human fecal microbiota composition, resulting in increased SCFA production. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1569052
|
4 |
Duygu Kirkik, Sevgi Kalkanli Tas. Unveiling the intricacies of irritable bowel syndrome. World Journal of Gastroenterology 2024; 30(44): 4763-4767 doi: 10.3748/wjg.v30.i44.4763
|